COVID-19 testing

OSCAR HEALTH INVESTORS: July 11, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on:

Tuesday, May 17, 2022 - 2:00pm

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Key Points:

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
In March 2021, Oscar Health completed its IPO, selling 36 million shares of Class A common stock at $39 per share, for proceeds of approximately $1.3 billion.
The National Law Journal has recognized Lieff Cabraser as one of the nations top plaintiffs law firms for fourteen years.

Progressive Care Reports First Quarter 2022 Financial Results Highlighted by 5% Growth in Revenue to $10.1 Million

Retrieved on:

Tuesday, May 17, 2022 - 12:00pm

Weisberg continued, Financially, we had a solid start to 2022, highlighted by our 5% revenue growth.

Key Points:

Weisberg continued, Financially, we had a solid start to 2022, highlighted by our 5% revenue growth.
Our recent expansion into long-term care pharmacy contracts provides Progressive Care with an opportunity to significantly increase its sales that produce much better margins.
Financial Results for Three Months Ended March 31, 2022
For the three months ended March 31, 2022 and 2021, we recognized overall revenue from operations of approximately $10.1 million and $9.6 million, respectively.
Prescription revenue for the three months ended March 31, 2022 was flat as compared to the same period in 2021.

Shareholder Alert: Robbins LLP informs Shareholders of Class Action Against Oscar Health, Inc.

Retrieved on:

Tuesday, May 17, 2022 - 8:21am

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Oscar Health, Inc. (NYSE: OSCR) securities pursuant to the Company's March 2021 initial public offering ("IPO").

Key Points:

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Oscar Health, Inc. (NYSE: OSCR) securities pursuant to the Company's March 2021 initial public offering ("IPO").
Oscar Health is a health insurance company that claims to be the first company "built around a full stack technology platform."
If you would like more information about Oscar Health, Inc.'s misconduct, click here .
Specifically, it omitted to state that Oscar was experiencing growing COVID-19 testing and treatment costs as well as growing net COVID-19 costs.

OSCAR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Oscar Health, Inc. and Encourages Investors to Contact the Firm

Retrieved on:

Tuesday, May 17, 2022 - 2:00am

Investors have until July 12, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until July 12, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
The Company also disclosed that its net loss for the quarter was $73.1 million, an increase of $32.1 million year-over-year.
Then, on November 10, 2021, Oscar disclosed that its third quarter 2021 MLR increased 920 basis points year-over-year, to 99.7%.

Skylight Health Group Reports First Quarter 2022 Financial Results

Retrieved on:

Monday, May 16, 2022 - 10:32pm

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (Skylight Health or the Company), a multi-state primary care management group in the United States, today announced its financial results for the first quarter ended March 31, 2022.

Key Points:

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (Skylight Health or the Company), a multi-state primary care management group in the United States, today announced its financial results for the first quarter ended March 31, 2022.
The launch of Athena Health EMR across all practices providing a strong foundation to manage practices across multiple markets efficiently and track operations and revenues.
Q1 2022 was an extension of efforts from 2021 and 2020 from both a healthy and robust market for raising equity and opportunities for acquisition.
Revenue was down 18% from the previous quarter increased 255% compared to the three months ended March 31, 2021.

MCI Onehealth Reports 30% Increase in Revenue, On Track for Record Year in Patient Visits

Retrieved on:

Monday, May 16, 2022 - 10:16pm

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, today released its financial results for the three- month period ended March 31, 2022.

Key Points:

Quarterly revenue of $13.0 million, on track for another record year in multiple business units.
Pipeline of up to $4 million worth of projects for health data insights expected from launch of MCIs data lake.
The financing is available to the Company upon request to ensure the Company executes on its strategic business plan.
The Companys concierge health care offering continues to add members organically, including a 12% increase in membership in the first quarter.

XpresSpa Group Reports First Quarter 2022 Results

Retrieved on:

Monday, May 16, 2022 - 9:05pm

Repurchased $11.1 Million of Shares During the First Quarter 2022, Intends to Complete Remaining Repurchase Authorizationas Opportunities Arise

Key Points:

Repurchased $11.1 Million of Shares During the First Quarter 2022, Intends to Complete Remaining Repurchase Authorizationas Opportunities Arise
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA), a travel health and wellness company, today reported that it has filed financial results on Form 10-Q for the first quarter ending March 31, 2022.
Scott Milford, XpresSpa Group CEO, stated, The foundation for the future of our company is built on four strategic imperatives.
During the first quarter, we recognized $1.4 million of revenue related to this contract with the remaining $2.6 million of the contract expected to be recognized in the second quarter.
While a decline in the first quarter relative to the fourth quarter last year was not surprising, as the first quarter is typically the weakest quarter in terms of airport traffic, the decrease was faster than projected.

Biocept Announces a Delay in the Filing of its Quarterly Report on Form 10-Q

Retrieved on:

Monday, May 16, 2022 - 9:05pm

(Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces a delay in the filing of its Quarterly Report on Form 10-Q for the three months ended March 31, 2022.

Key Points:

(Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces a delay in the filing of its Quarterly Report on Form 10-Q for the three months ended March 31, 2022.
Biocept expects to file its Form 10-Q on or before May 23, 2022.
Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers.
Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Ginkgo Bioworks Reports First Quarter 2022 Financial Results

Retrieved on:

Monday, May 16, 2022 - 9:01pm

The update, including a webcast slide presentation with additional details on the first quarter and supplemental financial information, will be available at investors.ginkgobioworks.com .

Key Points:

The update, including a webcast slide presentation with additional details on the first quarter and supplemental financial information, will be available at investors.ginkgobioworks.com .
"We sometimes remark that the pace of change never seems to slow at Ginkgo, and the beginning of 2022 has been no exception," said Jason Kelly, co-founder and CEO of Ginkgo.
Ginkgo has included these non-GAAP financial measures because it believes they provide an additional tool for investors to use in evaluating Ginkgo's financial performance and prospects.
In addition, these non-GAAP financial measures may differ from non-GAAP financial measures with comparable names used by other companies.

EQUITY ALERT: Rosen Law Firm Encourages Oscar Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – OSCR

Retrieved on:

Monday, May 16, 2022 - 7:37pm

WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq.

Key Points:

WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.